» Articles » PMID: 18834512

Human ESCs Predisposition to Karyotypic Instability: Is a Matter of Culture Adaptation or Differential Vulnerability Among HESC Lines Due to Inherent Properties?

Overview
Journal Mol Cancer
Publisher Biomed Central
Date 2008 Oct 7
PMID 18834512
Citations 65
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The use of human embryonic stem cells (hESCs) in research is increasing and hESCs hold the promise for many biological, clinical and toxicological studies. Human ESCs are expected to be chromosomally stable since karyotypic changes represent a pitfall for potential future applications. Recently, several studies have analysed the genomic stability of several hESC lines maintained after prolonged in vitro culture but controversial data has been reported. Here, we prompted to compare the chromosomal stability of three hESC lines maintained in the same laboratory using identical culture conditions and passaging methods.

Results: Molecular cytogenetic analyses performed in three different hESC lines maintained in parallel in identical culture conditions revealed significant differences among them in regard to their chromosomal integrity. In feeders, the HS181, SHEF-1 and SHEF-3 hESC lines were chromosomally stable up to 185 passages using either mechanical or enzymatic dissection methods. Despite the three hESC lines were maintained under identical conditions, each hESC line behaved differently upon being transferred to a feeder-free culture system. The two younger hESC lines, HS181 (71 passages) and SHEF-3 (51 passages) became chromosomally unstable shortly after being cultured in feeder-free conditions. The HS181 line gained a chromosome 12 by passage 17 and a marker by passage 21, characterized as a gain of chromosome 20 by SKY. Importantly, the mosaicism for trisomy 12 gradually increased up to 89% by passage 30, suggesting that this karyotypic abnormality provides a selective advantage. Similarly, the SHEF-3 line also acquired a trisomy of chromosome 14 as early as passage 10. However, this karyotypic aberration did not confer selective advantage to the genetically abnormal cells within the bulk culture and the level of mosaicism for the trisomy 14 remained overtime between 15%-36%. Strikingly, however, a much older hESC line, SHEF-1, which was maintained for 185 passages in feeders did not undergo any numerical or structural chromosomal change after 30 passages in feeder-free culture and over 215 passages in total.

Conclusion: These results support the concept that feeder-free conditions may partially contribute to hESC chromosomal changes but also confirm the hypothesis that regardless of the culture conditions, culture duration or splitting methods, some hESC lines are inherently more prone than others to karyotypic instability.

Citing Articles

Variable patterns of retrotransposition in different HeLa strains provide mechanistic insights into SINE RNA mobilization processes.

Moldovan J, Kopera H, Liu Y, Garcia-Canadas M, Catalina P, Leone P Nucleic Acids Res. 2024; 52(13):7761-7779.

PMID: 38850156 PMC: 11260458. DOI: 10.1093/nar/gkae448.


Sex in cardiovascular disease: Why this biological variable should be considered in in vitro models.

McClain A, Monteleone P, Zoldan J Sci Adv. 2024; 10(19):eadn3510.

PMID: 38728407 PMC: 11086622. DOI: 10.1126/sciadv.adn3510.


Trisomy 12 compromises the mesendodermal differentiation propensity of human pluripotent stem cells.

Yanagihara K, Hayashi Y, Liu Y, Yamaguchi T, Hemmi Y, Kokunugi M In Vitro Cell Dev Biol Anim. 2024; 60(5):521-534.

PMID: 38169039 PMC: 11126453. DOI: 10.1007/s11626-023-00824-9.


Gains of 20q11.21 in human pluripotent stem cells: Insights from cancer research.

Krivec N, Ghosh M, Spits C Stem Cell Reports. 2023; 19(1):11-27.

PMID: 38157850 PMC: 10828824. DOI: 10.1016/j.stemcr.2023.11.013.


Quality Control Optimization for Minimizing Security Risks Associated with Mesenchymal Stromal Cell-Based Product Development.

Rebelatto C, Boldrini-Leite L, Daga D, Marsaro D, Vaz I, Jamur V Int J Mol Sci. 2023; 24(16).

PMID: 37629136 PMC: 10455270. DOI: 10.3390/ijms241612955.


References
1.
Draper J, Smith K, Gokhale P, Moore H, Maltby E, Johnson J . Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat Biotechnol. 2003; 22(1):53-4. DOI: 10.1038/nbt922. View

2.
Wilton L . Preimplantation genetic diagnosis for aneuploidy screening in early human embryos: a review. Prenat Diagn. 2002; 22(6):512-8. DOI: 10.1002/pd.388. View

3.
Thomson J, Itskovitz-Eldor J, Shapiro S, Waknitz M, Swiergiel J, Marshall V . Embryonic stem cell lines derived from human blastocysts. Science. 1998; 282(5391):1145-7. DOI: 10.1126/science.282.5391.1145. View

4.
Inzunza J, Gertow K, Stromberg M, Matilainen E, Blennow E, Skottman H . Derivation of human embryonic stem cell lines in serum replacement medium using postnatal human fibroblasts as feeder cells. Stem Cells. 2005; 23(4):544-9. DOI: 10.1634/stemcells.2004-0201. View

5.
Maitra A, Arking D, Shivapurkar N, Ikeda M, Stastny V, Kassauei K . Genomic alterations in cultured human embryonic stem cells. Nat Genet. 2005; 37(10):1099-103. DOI: 10.1038/ng1631. View